Mirum Pharmaceuticals Inc...

NASDAQ: MIRM · Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.93
0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT

Mirum Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
336.89M 186.37M 77.06M 19.14M
Cost of Revenue
81.64M 47.04M 12.37M 1.9M
Gross Profit
255.25M 139.34M 64.69M 17.23M
Operating Income
-87.61M -109.15M -131.22M -173.41M
Interest Income
13.79M 13.73M 3.86M 366K
Pretax Income
-86.91M -162.42M -142.07M -83.95M
Net Income
-87.94M -163.41M -135.66M -83.99M
Selling & General & Admin
202.22M 145.88M 89.07M 59.22M
Research & Development
140.63M 102.61M 106.84M 131.43M
Other Expenses
n/a n/a 365K n/a
Operating Expenses
342.85M 248.49M 195.91M 190.65M
Interest Expense
14.31M 15.11M 15.98M 17.59M
Selling & Marketing Expenses
n/a 6.3M 72.11M 9.2M
Cost & Expenses
424.49M 295.53M 208.28M 192.55M
Income Tax Expense
1.03M 991K -6.41M 37K
Shares Outstanding (Basic)
47.52M 40.89M 33.84M 30.32M
Shares Outstanding (Diluted)
47.52M 40.89M 33.84M 30.32M
EPS (Basic)
-1.85 -4 -4.01 -2.77
EPS (Diluted)
-1.85 -4 -4.01 -2.77
EBITDA
-48.97M -136.49M -122.41M -65.39M
EBIT
-72.6M -147.32M -126.09M -66.36M
Depreciation & Amortization
23.63M 10.83M 3.68M 975K